ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 233 filers reported holding ROYALTY PHARMA PLC in Q3 2021. The put-call ratio across all filers is 0.36 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,786 | -76.8% | 58,095 | -72.8% | 0.17% | -78.4% |
| Q1 2023 | $7,690 | -11.5% | 213,430 | -3.0% | 0.78% | -15.9% |
| Q4 2022 | $8,692 | -99.9% | 219,940 | -3.6% | 0.93% | -10.2% |
| Q3 2022 | $9,171,000 | -5.8% | 228,250 | -1.4% | 1.04% | +3.8% |
| Q2 2022 | $9,734,000 | +8.8% | 231,545 | +0.8% | 1.00% | +41.5% |
| Q1 2022 | $8,949,000 | -1.5% | 229,685 | +0.8% | 0.71% | +7.3% |
| Q4 2021 | $9,083,000 | +8.7% | 227,935 | -1.5% | 0.66% | +6.8% |
| Q3 2021 | $8,359,000 | +17.9% | 231,305 | +33.7% | 0.62% | +26.0% |
| Q2 2021 | $7,092,000 | -5.7% | 173,025 | +0.3% | 0.49% | -15.4% |
| Q1 2021 | $7,523,000 | -13.1% | 172,475 | -0.3% | 0.58% | -18.1% |
| Q4 2020 | $8,657,000 | +33.4% | 172,975 | +12.1% | 0.71% | +12.8% |
| Q3 2020 | $6,489,000 | – | 154,250 | – | 0.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
| Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
| Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
| Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
| Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
| TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
| Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
| Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
| Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |